SEARCH

SEARCH BY CITATION

References

  • 1
    Etemad B , Whitcomb DC . Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682707.
  • 2
    Nair RJ , Lawler L , Miller MR . Chronic pancreatitis. Am Fam Physician 2007; 76: 167988.
  • 3
    Braganza JM , Lee SH , McCloy RF , McMahon MJ . Chronic pancreatitis. Lancet 2011; 377: 118497.
  • 4
    Coté GA , Yadav D , Slivka A , et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2011; 9: 26673.
  • 5
    Balakrishnan V , Unnikrishnan AG , Thomas V , et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 2008; 9: 593600.
  • 6
    Tandon RK , Sato N , Garg PK . Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol 2002; 17: 50818.
  • 7
    Barman KK , Premalatha G , Mohan V . Tropical chronic pancreatitis. Postgrad Med J 2003; 79: 60615.
  • 8
    Balakrishnan V , Nair P , Radhakrishnan L , Narayanan VA . Tropical pancreatitis - a distinct entity, or merely a type of chronic pancreatitis? Indian J Gastroenterol 2006; 25: 7481.
  • 9
    Mahurkar S , Reddy DN , Rao GV , Chandak GR . Genetic mechanisms underlying the pathogenesis of tropical calcific pancreatitis. World J Gastroenterol 2009; 15: 2649.
  • 10
    Domínguez-Muñoz JE . Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9: 11622.
  • 11
    Layer P , Yamamoto H , Kalthoff L , Clain JE , Bakken LJ , DiMagno EP . The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 14817.
  • 12
    Bhasin DK , Singh G , Rana SS , et al. Clinical profile of idiopathic chronic pancreatitis in North India. Clin Gastroenterol Hepatol 2009; 7: 5949.
  • 13
    Whitcomb DC , Lehman GA , Vasileva G , et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol 2010; 105: 227686. Erratum in Am J Gastroenterol 2011; 106: 1177-8.
  • 14
    Safdi M , Bekal PK , Martin S , Saeed ZA , Burton F , Toskes PP . The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 15662.
  • 15
    Mohan V , Poongothai S , Pitchumoni CS . Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int J Pancreatol 1998; 24: 1922.
  • 16
    Trapnell BC , Maguiness K , Graff GR , Boyd D , Beckmann K , Caras S . Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros 2009; 8: 3707.
  • 17
    Graff GR , Maguiness K , McNamara J , et al. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Clin Ther 2010; 32: 89103.
  • 18
    Graff GR , McNamara J , Royall J , Caras S , Forssmann K . Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON®) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Clin Drug Investig 2010; 30: 35164.
  • 19
    Stern RC , Eisenberg JD , Wagener JS , et al. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000; 95: 19328.
    Direct Link:
  • 20
    Munck A , Duhamel JF , Lamireau T , et al. Pancreatic enzyme replacement therapy for young cystic fibrosis patients. J Cyst Fibros 2009; 8: 148.
  • 21
    Colombo C , Fredella C , Russo MC , et al. Efficacy and tolerability of Creon for children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Pancreas 2009; 38: 6939.
  • 22
    Littlewood JM , Connett GJ , Sander-Struckmeier S , Henniges F . A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis. Expert Opin Drug Saf 2011; 10: 197203.
  • 23
    Van De Kamer JH , Ten Bokkel Huinink H , Weyers HA . Rapid method for the determination of fat in feces. J Biol Chem 1949; 177: 34755.
  • 24
    Gubergrits N , Malecka-Panas E , Lehman GA , et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33: 115261.
  • 25
    Toskes PP , Secci A , Thieroff-Ekerdt R . Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas 2011; 40: 37682.
  • 26
    Abdel Aziz AM , Lehman GA . Current treatment options for chronic pancreatitis. Curr Treat Options Gastroenterol 2007; 10: 35568.
  • 27
    Layer P , Keller J , Lankisch PG . Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001; 3: 1018.